• CGRP in migraine: current therapeutics, future implications and potential off-target effects

  • Dec 21 2021
  • Length: 10 mins
  • Podcast
CGRP in migraine: current therapeutics, future implications and potential off-target effects By cover art

CGRP in migraine: current therapeutics, future implications and potential off-target effects

Listen for free

View show details

  • Summary

  • In this podcast, JNNP's Podcast Editor, Colin Mahoney, interviews Dr Jason Ray (Neurology, Alfred Health, and Department of Neuroscience, Monash University, Melbourne). Dr Ray discusses the role of calcitonin gene related peptide in migraine and the growing body of evidence for the role of therapies directed against this protein in migraine and beyond. He also highlights emerging off-target side effects to monitor for.

    Related article: https://jnnp.bmj.com/content/92/12/1325
    Show more Show less
Physical Illness & Disease Hygiene & Healthy Living
Show more Show less

What listeners say about CGRP in migraine: current therapeutics, future implications and potential off-target effects

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com reviews

Amazon reviews
No Reviews are Available